#ORIC

Lead report

ORIC Pharmaceuticals GAAP EPS of -$0.38 misses by $0.02 (ORIC:NASDAQ)

ORIC Pharmaceuticals (ORIC) Q2 GAAP EPS -$0.38 misses by $0.02; cash/investments $387.6M funds operations into 2H 2028.